Moreover, mortality alone is an insufficient means to measure the impact of CAD, as it is also the leading global cause of cardiovascular morbidity, imposing over 200 million disability-adjusted life years on patients living with the sequelae of ischemic cardiomyopathy
In short, in 1975 a medical student in Zagreb named Dr
Niswender K, Pi-Sunyer X, Buse J et al (2013) Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme
doi:10.1016/j.dsx.2022.102427 Alexander JT, Staab EM, Wan W, et al
At Boca Medical Care, we recognize that every patients needs are unique
Ne e Yarar